Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research for the Molecular Imaging of the PD-L1 Targeting Tracer

NCT04304066 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT04304066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04304066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research for the Molecular Imaging of the PD-L1 Targeting Tracer
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 6, 2019
Completion date
December 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, solid tumor